U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07119190) titled 'A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy' on July 15.

Brief Summary: The goal of this study is to develop and refine an integrated minimally invasive care pathway for resectable lung cancer in the immunotherapy era, establishing a novel precision perioperative immunotherapy paradigm encompassing original techniques and clinical applications.

Study Start Date: Aug. 06

Study Type: OBSERVATIONAL

Condition: Non-Small Cell Lung Cancer

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Peking University People's Hospital

Information provided by (Responsible Pa...